Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma.
Yang H, Xiang B, Song Y, Zhang H, Zhao W, Zou D, Lv F, Guo W, Liu A, Li C, Tan Z, Liu Y, Fu L, Guo H, Novotny W, Huang J, Li Y.
Yang H, et al. Among authors: guo w, guo h.
Blood Adv. 2022 Mar 22;6(6):1629-1636. doi: 10.1182/bloodadvances.2020003698.
Blood Adv. 2022.
PMID: 34638136
Free PMC article.